Related Experiment Video
Updated: Jul 20, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Atypical cutaneous leishmaniasis in two patients receiving low-dose methotrexate
1Department of Dermatology, Bristol Royal Infirmary, Bristol, UK. monikasaha@doctors.net.uk
Abstract:
Cutaneous leishmaniasis is a protozoan disease that has high morbidity. There have been increasing reports of leishmaniasis in patients with an underlying immunosuppressed state. We present two cases of cutaneous leishmaniasis caused by Old World species in patients on methotrexate therapy. We postulate that the T-cell-mediated response to leishmaniasis infection could be modulated by methotrexate and may render an immunosuppressed individual more susceptible to developing clinical disease.
Related Concept Videos
Antiprotozoal Agents
Leishmaniasis
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Therapeutic Drug Monitoring: Affecting Factors